½ÃÀ庸°í¼­
»óǰÄÚµå
1608147

¼¼°èÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀå : À¯Çü, ¸ð´Þ¸®Æ¼, ¿ëµµº° ¿¹Ãø(2025-2030³â)

Intraoperative Neuromonitoring Market by Type (Insource IONM, Outsource IONM), Modality (Brainstem Auditory Evoked Potentials, Electroencephalography, Electromyography), Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 194 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀåÀº 2023³â¿¡ 31¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 33¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 5.69%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 46¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM)Àº ½Å°æ °æ·Î¸¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÏ°í ½Å°æ°ú ô¼öÀÇ ¼Õ»ó À§ÇèÀ» ÁÙÀ̱â À§ÇØ ¼ö¼ú Áß¿¡ »ç¿ëµÇ´Â Ư¼ö Ä¡·áÀÔ´Ï´Ù. Á¦°ø, ƯÈ÷ ³ú, ôÃß, ½Å°æÀ» Æ÷ÇÔÇÑ º¹ÀâÇÑ ¼ö¼ú Áß È¯ÀÚÀÇ ¾ÈÀü¼º ¸¦ ³ôÀÏ ¼ö ÀÖ´Â °Í¿¡ À¯·¡ÇÕ´Ï´Ù. IONMÀÇ ¿ëµµ´Â Æø³Ð°Ô, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, Ç÷°ü¿Ü°ú, À̺ñÀÎÈİú¿¡ À̸¥´Ù ÃÖÁ¾ ¿ëµµ¿¡´Â º´¿ø, ¼ö¼ú¼¾ÅÍ, Àü¹® Ŭ¸®´Ð µîÀÌ Æ÷ÇԵǾî, ¼ö¼ú °Ç¼ö Áõ°¡¿Í ¼ö¼ú ÇÕº´ÁõÀ» ÃÖ¼ÒÈ­ÇÏ°í ½Í´Ù´Â ¿ä±¸°¡ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 31¾ï 3,000¸¸ ´Þ·¯
ÃßÁ¤³â(2024) 33¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 46¾ï 2,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 5.69%

½ÃÀå ÀλçÀÌÆ®¿¡ µû¸£¸é ±â¼ú Áøº¸, ¼ö¼úÀÌ ´õ ¸¹Àº ³ëÈ­, ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ ÀÇ·á Àü¹®°¡ÀÇ ÀÇ½Ä Áõ°¡ µî ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¸î °¡Áö ÁÖ¿ä ¿äÀÎÀÌ ¹àÇôÁ³½À´Ï´Ù. Çß½À´Ï´Ù. ÇコÄɾî ÀÎÇÁ¶ó°¡ È®´ëµÇ´Â ½ÅÈï ½ÃÀå°ú ¸ð´ÏÅ͸µ Á¤È®µµ¿Í ¿¹Ãø ºÐ¼®À» °­È­Çϱâ À§ÇÑ ÀΰøÁö´É°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕ¿¡´Â ºñÁî´Ï½º ±âȸ°¡ dzºÎÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¸¦ Æ÷ÂøÇϱâ À§ÇØ, ±â¾÷µéÀº ÀÌ·¯ÇÑ Áö¿ª¿¡¼­ÀÇ ÇöÀå È®´ë¿Í º¸´Ù Á¤±³ÇÏ°í »ç¿ëÇϱ⠽¬¿î ÀåºñÀÇ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ¿¡ ÁÖ·ÂÇØ¾ß ÇÕ´Ï´Ù.

½ÃÀå ¼ºÀåÀ» ¹æÇØÇÏ´Â °úÁ¦·Î´Â Àåºñ ºñ¿ëÀÇ ³ôÀÌ, IONM ±â¼úÀ» ¿î¿ëÇÏ´Â ¼÷·Ã Àü¹®°¡ÀÇ ºÎÁ·, º¹ÀâÇÑ ±ÔÁ¦»óÀÇ Àå¾Ö¹° µîÀÌ ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ±â¼ú Çõ½ÅÀÇ ¼Óµµ°¡ ºü¸£±â ¶§¹®¿¡ °Ç°­ °ü¸® Á¦°ø¾÷ü´Â Ç×»ó ÀûÀÀÇØ¾ß Çϸç, ÀÌ´Â º¸±Þ À庮ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀº ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼Ç °³¹ß, ¹«¼± ¿¬°á ¹× ±âŸ ¼ö¼ú ½Ã½ºÅÛ °£ÀÇ »óÈ£ ¿î¿ë¼º °­È­¿¡ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù. ºñħ½ÀÀû ¸ð´ÏÅ͸µ ±â¼úÀ» Á¶»çÇÏ¸é ºñÁî´Ï½º ¼ºÀåÀÇ »õ·Î¿î ±æÀ» ¿­ ¼ö ÀÖ½À´Ï´Ù. IONM ½ÃÀåÀÇ º»ÁúÀº ¿ªµ¿ÀûÀÌ¸ç ²÷ÀÓ¾ø´Â ±â¼ú Çõ½Å°ú °æÀï ±¸µµÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ±â¾÷Àº °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ Àü·«Àû ÆÄÆ®³Ê½Ê, Áö¼ÓÀûÀÎ ±â¼ú ¾÷µ¥ÀÌÆ®, ÀÇ·á Àü¹®°¡¸¦ À§ÇÑ Á¾ÇÕÀûÀÎ ±³À° ÇÁ·Î±×·¥À» ¿ì¼±ÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °úÁ¦¿¡ Àû±ØÀûÀ¸·Î ´ëóÇÏ°í ½Å±â¼úÀ» Ȱ¿ëÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀåÀ» °¡¼ÓÇÏ°í ½ÃÀå¿¡¼­ÀÇ Á¸Àç°¨À» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. È­¿Í »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÏ´Â °Í ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¶ÇÇÑ ¼ÒºñÀÚ Çൿ ±×¸®°í ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ´Ù¾çÇÑ ¶óÀÌÇÁ½ºÅ¸Àϰú °ü·ÃµÈ ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡
    • È£ÀÇÀûÀÎ »óȯÁ¤Ã¥°ú º¸´Ù ¾ÈÀüÇÑ ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä
    • ¾Æ¿ô¼Ò½ÌÀÇ µ¿ÇâÀÇ ³ô¾Æ ¼ö¼úÁß ½Å°æ ¸ð´ÏÅ͸µ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Ä¡·áºñÀÇ »ó½Â
  • ½ÃÀå ±âȸ
    • ¼ö¼ú Áß À§ÇèÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇÑ ½Å°æ ¸ð´ÏÅ͸µÀÇ ±â¼úÀû Áøº¸
    • Á¤ºÎ±â°ü¿¡ ÀÇÇÑ R&D ÅõÀÚ Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·°ú ÀÎÁöµµÀÇ ³·À½

Porter's Five Forces : ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϰí ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÔÀ¸·Î½á º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ °¡´ÉÇÕ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼®¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.¤·

Àü·« ºÐ¼® ¹× Ãßõ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇöÀå °­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ´Ù¾çÇÑ ¶óÀÌÇÁ½ºÅ¸Àϰú °ü·ÃµÈ ¸¸¼ºÁúȯ Áõ°¡
      • À¯¸®ÇÑ »óȯ ¹æÄ§°ú º¸´Ù ¾ÈÀüÇÑ ¼ö¼ú ¹æ¹ýÀÇ ¿ä±¸
      • ¾Æ¿ô¼Ò½Ì Áõ°¡ °æÇâ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ
    • ¾ïÁ¦¿äÀÎ
      • Ä¡·áºñ°¡ ³ô´Ù
    • ±âȸ
      • ¼ö¼ú Áß À§ÇèÀ» ÃÖ¼ÒÈ­ÇÏ´Â ½Å°æ ¸ð´ÏÅ͸µÀÇ ±â¼úÀû Áøº¸
      • Á¤ºÎ±â°ü¿¡ ÀÇÇÑ R&D ÅõÀÚ Áõ°¡
    • °úÁ¦
      • ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·°ú ÀǽÄÀÇ ³·À½
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀå : À¯Çüº°

  • ÀÎ ¼Ò½º IONM
  • IONMÀ» ¾Æ¿ô¼Ò½Ì

Á¦7Àå ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀå : ¸ð´Þ¸®Æ¼º°

  • ³ú°£ û°¢ À¯¹ß ÀüÀ§
  • ³úÆÄ °Ë»ç
  • ±ÙÀüµµ °Ë»ç
  • ¿îµ¿À¯¹ß ÀüÀ§
  • ü¼º °¨°¢ À¯¹ß ÀüÀ§
  • ½Ã°¢À¯¹ß ÀüÀ§

Á¦8Àå ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀå : ¿ëµµº°

  • À̺ñÀÎÈİú ¼ö¼ú
  • ³ú½Å°æ¿Ü°ú
  • Á¤Çü¿Ü°ú
  • ôÃß ¼ö¼ú
  • Ç÷°ü ¼ö¼ú

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Accurate Monitoring, LLC
  • Argos Neuromonitoring LP
  • Biotronic NeuroNetwork, LLC
  • Cadwell Industries, Inc.
  • Computational Diagnostics, Inc.
  • Emotiv Inc.
  • inomed Medizintechnik GmbH
  • Intranerve, LLC
  • Medsurant Health
  • Medtronic PLC
  • Moberg Research Inc.
  • Natus Medical Incorporated
  • NeuroMonitoring Technologies
  • NeuroSentinel LLC
  • Nihon Kohden Corporation
  • NuVasive Inc
  • Procirca
  • ProPep Surgical
  • SpecialtyCare, Inc.
BJH 24.12.19

The Intraoperative Neuromonitoring Market was valued at USD 3.13 billion in 2023, expected to reach USD 3.31 billion in 2024, and is projected to grow at a CAGR of 5.69%, to USD 4.62 billion by 2030.

Intraoperative neuromonitoring (IONM) is a specialized procedure used during surgeries to monitor the neural pathways in real-time, reducing the risk of nerve or spinal cord damage. The necessity of IONM stems from its ability to provide immediate feedback to surgeons, enhancing patient safety, particularly during complex surgeries involving the brain, spine, and nerves. Its applications are broad, spanning orthopedic, neurosurgical, vascular, and ENT procedures. The end-use scope includes hospitals, surgical centers, and specialty clinics, where demand is driven by the increasing volume of surgeries and the desire to minimize surgical complications.

KEY MARKET STATISTICS
Base Year [2023] USD 3.13 billion
Estimated Year [2024] USD 3.31 billion
Forecast Year [2030] USD 4.62 billion
CAGR (%) 5.69%

Market insights reveal several key factors influencing growth, including technological advancements, an aging population requiring more surgeries, and increasing awareness among healthcare professionals about patient safety benefits. Opportunities abound in emerging markets, where healthcare infrastructure is expanding, and in the integration of artificial intelligence and machine learning to enhance monitoring accuracy and predictive analytics. To seize these opportunities, companies should focus on expanding their presence in these regions and investing in R&D for more sophisticated, user-friendly devices.

Challenges impeding market growth include high equipment costs, a shortage of skilled professionals to operate IONM technologies, and complex regulatory hurdles. Furthermore, the rapid pace of technological change demands constant adaptation by healthcare providers, which can be a barrier for widespread adoption.

Innovation should concentrate on developing cost-effective solutions and enhancing wireless connectivity and interoperability with other surgical systems. Research into non-invasive monitoring techniques could offer new avenues for business growth. The nature of the IONM market is dynamic, characterized by continuous technological innovations and a competitive landscape. Businesses should prioritize strategic partnerships, continuous technological updates, and comprehensive training programs for healthcare professionals to maintain a competitive edge. By being proactive in addressing these challenges and leveraging new technologies, businesses can drive growth and establish a strong market presence.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intraoperative Neuromonitoring Market

The Intraoperative Neuromonitoring Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of various lifestyles associated chronic diseases
    • Favorable reimbursement policies and demand for safer surgery practices
    • Rising trend of outsourcing Intraoperative Neuromonitoring
  • Market Restraints
    • High cost of treatment
  • Market Opportunities
    • Technological advancements in neuromonitoring to minimize the risks during surgery
    • Increased R&D investments by governmental bodies
  • Market Challenges
    • Dearth of skilled professionals and low awareness

Porter's Five Forces: A Strategic Tool for Navigating the Intraoperative Neuromonitoring Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intraoperative Neuromonitoring Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intraoperative Neuromonitoring Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intraoperative Neuromonitoring Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intraoperative Neuromonitoring Market

A detailed market share analysis in the Intraoperative Neuromonitoring Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intraoperative Neuromonitoring Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intraoperative Neuromonitoring Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intraoperative Neuromonitoring Market

A strategic analysis of the Intraoperative Neuromonitoring Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intraoperative Neuromonitoring Market, highlighting leading vendors and their innovative profiles. These include Accurate Monitoring, LLC, Argos Neuromonitoring LP, Biotronic NeuroNetwork, LLC, Cadwell Industries, Inc., Computational Diagnostics, Inc., Emotiv Inc., inomed Medizintechnik GmbH, Intranerve, LLC, Medsurant Health, Medtronic PLC, Moberg Research Inc., Natus Medical Incorporated, NeuroMonitoring Technologies, NeuroSentinel LLC, Nihon Kohden Corporation, NuVasive Inc, Procirca, ProPep Surgical, and SpecialtyCare, Inc..

Market Segmentation & Coverage

This research report categorizes the Intraoperative Neuromonitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Insource IONM and Outsource IONM.
  • Based on Modality, market is studied across Brainstem Auditory Evoked Potentials, Electroencephalography, Electromyography, Motor Evoked Potentials, Somatosensory Evoked Potentials, and Visual Evoked Potentials.
  • Based on Application, market is studied across ENT Surgery, Neurosurgery, Orthopedic Surgery, Spinal Surgery, and Vascular Surgery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of various lifestyles associated chronic diseases
      • 5.1.1.2. Favorable reimbursement policies and demand for safer surgery practices
      • 5.1.1.3. Rising trend of outsourcing Intraoperative Neuromonitoring
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in neuromonitoring to minimize the risks during surgery
      • 5.1.3.2. Increased R&D investments by governmental bodies
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professionals and low awareness
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intraoperative Neuromonitoring Market, by Type

  • 6.1. Introduction
  • 6.2. Insource IONM
  • 6.3. Outsource IONM

7. Intraoperative Neuromonitoring Market, by Modality

  • 7.1. Introduction
  • 7.2. Brainstem Auditory Evoked Potentials
  • 7.3. Electroencephalography
  • 7.4. Electromyography
  • 7.5. Motor Evoked Potentials
  • 7.6. Somatosensory Evoked Potentials
  • 7.7. Visual Evoked Potentials

8. Intraoperative Neuromonitoring Market, by Application

  • 8.1. Introduction
  • 8.2. ENT Surgery
  • 8.3. Neurosurgery
  • 8.4. Orthopedic Surgery
  • 8.5. Spinal Surgery
  • 8.6. Vascular Surgery

9. Americas Intraoperative Neuromonitoring Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intraoperative Neuromonitoring Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intraoperative Neuromonitoring Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accurate Monitoring, LLC
  • 2. Argos Neuromonitoring LP
  • 3. Biotronic NeuroNetwork, LLC
  • 4. Cadwell Industries, Inc.
  • 5. Computational Diagnostics, Inc.
  • 6. Emotiv Inc.
  • 7. inomed Medizintechnik GmbH
  • 8. Intranerve, LLC
  • 9. Medsurant Health
  • 10. Medtronic PLC
  • 11. Moberg Research Inc.
  • 12. Natus Medical Incorporated
  • 13. NeuroMonitoring Technologies
  • 14. NeuroSentinel LLC
  • 15. Nihon Kohden Corporation
  • 16. NuVasive Inc
  • 17. Procirca
  • 18. ProPep Surgical
  • 19. SpecialtyCare, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦